Indication

Alzheimer's disease

Alzheimer's disease is an irreversible, progressive neurodegenerative disorder of the central nervous system and the most common cause of dementia in older adults. Read more about Alzheimer's disease

3 drugs 2 manufacturers

Advertisement

Drugs that treat it

Common Alzheimer's disease therapies.

Showing 1–3 of 3 drugs

KISUNLA (donanemab-azbt)

ALZHEIMER'S DISEASE AGENTS - AMYLOID DIRECTED MC ANTIBODY·ALZHEIMER'S DISEASE
Eli Lilly and Company
Filter & compare in the drug finder →Opens the drug finder with Alzheimer's disease preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Alzheimer's disease.

Alzheimer's disease is an irreversible, progressive neurodegenerative disorder of the central nervous system and the most common cause of dementia in older adults.

Pathophysiologically, it is defined by the extracellular accumulation of amyloid-beta plaques, the intracellular aggregation of hyperphosphorylated tau proteins into neurofibrillary tangles, widespread synaptic dysfunction, and neuronal loss predominantly in the hippocampus and cerebral cortex.

Clinically, the disease characteristically presents with insidious short-term memory impairment and gradually advances to severe deficits in executive function, language, visuospatial abilities, and behavioral regulation, ultimately compromising the individual's ability to perform routine activities of daily living.

Personalize your experience

Follow Alzheimer's disease and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it